202 related articles for article (PubMed ID: 26261988)
1. HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.
Martín P; Krsnik I; Navarro B; Provencio M; García JF; Bellas C; Vilches C; Gomez-Lozano N
PLoS One; 2015; 10(8):e0135512. PubMed ID: 26261988
[TBL] [Abstract][Full Text] [Related]
2. Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.
Johnson PC; McAulay KA; Montgomery D; Lake A; Shield L; Gallagher A; Little AM; Shah A; Marsh SG; Taylor GM; Jarrett RF
Int J Cancer; 2015 Sep; 137(5):1066-75. PubMed ID: 25648508
[TBL] [Abstract][Full Text] [Related]
3. Association of DDX58 177 C > T polymorphism with decreased risk of Epstein-Barr virus-related nodular sclerosis classical Hodgkin lymphoma.
Martin P; Martínez-Velasquez J; Coronado MJ; Krsnik I; Provencio M; Navarro B; Moraru M; Bellas C; Vilches C; Gomez-Lozano N
Leuk Lymphoma; 2017 Feb; 58(2):438-444. PubMed ID: 27267403
[TBL] [Abstract][Full Text] [Related]
4. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
Urayama KY; Jarrett RF; Hjalgrim H; Diepstra A; Kamatani Y; Chabrier A; Gaborieau V; Boland A; Nieters A; Becker N; Foretova L; Benavente Y; Maynadié M; Staines A; Shield L; Lake A; Montgomery D; Taylor M; Smedby KE; Amini RM; Adami HO; Glimelius B; Feenstra B; Nolte IM; Visser L; van Imhoff GW; Lightfoot T; Cocco P; Kiemeney L; Vermeulen SH; Holcatova I; Vatten L; Macfarlane GJ; Thomson P; Conway DI; Benhamou S; Agudo A; Healy CM; Overvad K; Tjønneland A; Melin B; Canzian F; Khaw KT; Travis RC; Peeters PH; González CA; Quirós JR; Sánchez MJ; Huerta JM; Ardanaz E; Dorronsoro M; Clavel-Chapelon F; Bueno-de-Mesquita HB; Riboli E; Roman E; Boffetta P; de Sanjosé S; Zelenika D; Melbye M; van den Berg A; Lathrop M; Brennan P; McKay JD
J Natl Cancer Inst; 2012 Feb; 104(3):240-53. PubMed ID: 22286212
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigens and genetic susceptibility to lymphoma.
McAulay KA; Jarrett RF
Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
[TBL] [Abstract][Full Text] [Related]
7. The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma.
Jones K; Wockner L; Brennan RM; Keane C; Chattopadhyay PK; Roederer M; Price DA; Cole DK; Hassan B; Beck K; Gottlieb D; Ritchie DS; Seymour JF; Vari F; Crooks P; Burrows SR; Gandhi MK
Clin Exp Immunol; 2016 Feb; 183(2):206-20. PubMed ID: 26422112
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.
Barros MH; Vera-Lozada G; Soares FA; Niedobitek G; Hassan R
Int J Cancer; 2012 Sep; 131(5):1142-52. PubMed ID: 22025264
[TBL] [Abstract][Full Text] [Related]
9. HLA class I associations with EBV+ post-transplant lymphoproliferative disorder.
Jones K; Wockner L; Thornton A; Gottlieb D; Ritchie DS; Seymour JF; Kumarasinghe G; Gandhi MK
Transpl Immunol; 2015 Mar; 32(2):126-30. PubMed ID: 25731678
[TBL] [Abstract][Full Text] [Related]
10. Reduced frequency of cytotoxic CD56
Pánisová E; Lünemann A; Bürgler S; Kotur M; Lazarovici J; Danu A; Kaulfuss M; Mietz J; Chijioke O; Münz C; Busson P; Berger C; Ghez D; Azzi T
Cancer Immunol Immunother; 2022 Jan; 71(1):13-24. PubMed ID: 33993319
[TBL] [Abstract][Full Text] [Related]
11. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.
Hjalgrim H; Rostgaard K; Johnson PC; Lake A; Shield L; Little AM; Ekstrom-Smedby K; Adami HO; Glimelius B; Hamilton-Dutoit S; Kane E; Taylor GM; McConnachie A; Ryder LP; Sundstrom C; Andersen PS; Chang ET; Alexander FE; Melbye M; Jarrett RF
Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6400-5. PubMed ID: 20308568
[TBL] [Abstract][Full Text] [Related]
12. Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups.
Huang X; Kushekhar K; Nolte I; Kooistra W; Visser L; Bouwman I; Kouprie N; Veenstra R; van Imhoff G; Olver B; Houlston RS; Poppema S; Diepstra A; Hepkema B; van den Berg A
Blood; 2011 Nov; 118(19):5211-7. PubMed ID: 21921049
[TBL] [Abstract][Full Text] [Related]
13. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment and RIG-I signaling molecules in Epstein Barr virus-positive and -negative classical Hodgkin lymphoma of the elderly.
Satoh T; Wada R; Yajima N; Imaizumi T; Yagihashi S
J Clin Exp Hematop; 2014; 54(1):75-84. PubMed ID: 24942949
[TBL] [Abstract][Full Text] [Related]
15. HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in China.
Huang X; Hepkema B; Nolte I; Kushekhar K; Jongsma T; Veenstra R; Poppema S; Gao Z; Visser L; Diepstra A; van den Berg A
PLoS One; 2012; 7(2):e31865. PubMed ID: 22355400
[TBL] [Abstract][Full Text] [Related]
16. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
17. Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma.
Jiang P; Nolte IM; Hepkema BG; Stulp M; van den Berg A; Diepstra A
Front Immunol; 2022; 13():829943. PubMed ID: 35154153
[TBL] [Abstract][Full Text] [Related]
18. PML nuclear bodies and SATB1 are associated with HLA class I expression in EBV+ Hodgkin lymphoma.
Liu Y; van den Berg A; Veenstra R; Rutgers B; Nolte I; van Imhoff G; Visser L; Diepstra A
PLoS One; 2013; 8(8):e72930. PubMed ID: 24009715
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory NKG2A
Vietzen H; Staber PB; Berger SM; Furlano PL; Kühner LM; Lubowitzki S; Pichler A; Strassl R; Cornelissen JJ; Puchhammer-Stöckl E
Front Immunol; 2023; 14():1183788. PubMed ID: 37426645
[TBL] [Abstract][Full Text] [Related]
20. HLA-A alleles of patients with pyothorax-associated lymphoma: anti-Epstein-Barr virus (EBV) host immune responses during the development of EBV latent antigen-positive lymphomas.
Kanno H; Ohsawa M; Hashimoto M; Iuchi K; Nakajima Y; Aozasa K
Int J Cancer; 1999 Aug; 82(5):630-4. PubMed ID: 10417757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]